U.S. House Democrats on May 17 unveiled a bill to provide $28 million in emergency funds to the Food and Drug Administration to help the regulatory agency respond to a nationwide shortage of infant formula and strengthen supervision of the industry.
U.S. House Democrats on May 17 unveiled a bill to provide $28 million to the Food and Drug Administration to help respond to a nationwide shortage of infant formula.
U.S. lawmakers attempting to cut the cost of insulin for more than a million Americans to $35 per month are unlikely to succeed as November elections draw near and complicate bipartisan support, health policy and political experts say.
White House launches COVID.gov amid push for more funds, booster shotsBNT162b2 (Pfizer and BioNTech), Congress, Coronavirus Cases, COVID-19 booster shots, COVID-19 Vaccines, Democrats, Funding, Health Officials, Immunocompromised, Joe Biden, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Websites, White House
The Biden administration on Wednesday launched a new website to provide a clearinghouse of information on COVID-19 as part of a continuing effort to prepare Americans to live with the coronavirus.
Since the release of the Democratic Party’s $3.5 trillion budget draft in early August, intraparty tensions have been high as debate roils over what to cut and how to trim it so that the price tag becomes more amenable. On November 3, after almost three months of discussion, one hurdle of contention seems to have been cleared: the Democrats have reached an agreement about how to lower the price of some prescription drugs.
Democratic Party lawmakers holding up proposed drug pricing reforms are among the largest beneficiaries of the pharmaceutical industry’s push to stave off price cuts, a Reuters analysis of public lobbying and campaign data shows.
Three U.S. senators – Republican Roger Wicker of Mississippi, Democrat John Hickenlooper of Colorado and independent Angus King of Maine – disclosed on Aug. 19 they had tested positive for Covid-19.
The U.S. Supreme Court on June 17 rejected a Republican bid that had been backed by former President Donald Trump’s administration to invalidate Obamacare, preserving the landmark healthcare law for the third time since the ACA’s 2010 enactment.
U.S. lawmakers from both parties and both houses of Congress introduced eight antitrust bills aimed at tackling the problem of high and rising drug prices, including bills to stop brand name drug companies from paying generic firms to stay off the market.
President Joe Biden scored his first legislative win as the House of Representatives passed his $1.9 trillion coronavirus relief package early Feb. 27, though Democrats face challenges to their hopes of using the bill to raise the minimum wage.